Dexcom Inc- 詳細介紹、公司背景、業務範圍、財務數據以及市場表現

關於 Dexcom Inc 公司

DexCom, Inc. 是一家醫療設備公司。該公司主要專注於設計、開發和商業化連續血糖監測 (CGM)，該系統用於患者、護理人員和臨牀醫生管理糖尿病和代謝健康。其產品包括 Dexcom G6、Dexcom G7、Stelo、Dexcom Share 和 Dexcom ONE。該公司通過創新的生物傳感技術讓人們掌控健康。Dexcom G6 是其集成的連續血糖監測系統 (iCGM)。Stelo 是專爲不使用胰島素的 II 型糖尿病患者設計的，是美國第一款非處方葡萄糖生物傳感器。Dexcom Share 遠程監控系統可與任何 Dexcom 系統一起使用，使用患者兼容移動設備上的應用程序。其 Dexcom G7 適用於患有 I 型或 II 型糖尿病的成人和兒童（2 歲以上），他們正在使用任何胰島素或藥物，有低血糖風險，以及患有妊娠糖尿病。

公司簡介

公司代碼DXCM

公司名稱Dexcom Inc

上市日期Apr 14, 2005

成立日期1999

CEOMr. Kevin R. Sayer

員工數量10300

證券類型Ordinary Share

年結日Apr 14

公司地址6340 Sequence Dr

城市SAN DIEGO

上市交易所NASDAQ Global Select Consolidated

國家United States of America

郵編92121

電話18582000200

網址https://www.dexcom.com/

公司代碼DXCM

上市日期Apr 14, 2005

成立日期1999

公司高階主管

名稱

名稱/職務

職務

持股

持股變動

Dr. Eric J. Topol, M.D.

Independent Director

380.55K

+0.77%

Mr. Jacob Steven (Jake) Leach

Executive Vice President, Chief Operating Officer

276.26K

+6.52%

Mr. Kevin R. Sayer

Chairperson of the Board, President, Chief Executive Officer

233.94K

+11.70%

Mr. Mark G. Foletta

Lead Independent Director

59.37K

-4.34%

Mr. Steven R. (Steve) Altman

Independent Director

58.63K

+5.18%

Mr. Richard Alexander Collins

Independent Director

41.94K

+7.44%

Mr. Jereme M. Sylvain

Chief Financial Officer, Executive Vice President

40.15K

+34.41%

Mr. Nicholas (Nick) Augustinos

Independent Director

39.70K

+8.30%

Ms. Bridgette P. Heller

Independent Director

23.00K

-1.51%

Mr. Kyle Malady

Independent Director

18.14K

--

名稱

名稱/職務

職務

持股

持股變動

Dr. Eric J. Topol, M.D.

Independent Director

380.55K

+0.77%

Mr. Jacob Steven (Jake) Leach

Executive Vice President, Chief Operating Officer

276.26K

+6.52%

Mr. Kevin R. Sayer

Chairperson of the Board, President, Chief Executive Officer

233.94K

+11.70%

Mr. Mark G. Foletta

Lead Independent Director

59.37K

-4.34%

Mr. Steven R. (Steve) Altman

Independent Director

58.63K

+5.18%

Mr. Richard Alexander Collins

Independent Director

41.94K

+7.44%

收入明細

單位: USD更新時間: 4月6日週日

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

FY2019

業務USD

名稱

營收

佔比

Distributor

3.43B

85.05%

Direct

602.90M

14.95%

地區USD

名稱

營收

佔比

United States

2.89B

71.65%

Outside of United states

1.14B

28.35%

業務

地區

業務USD

名稱

營收

佔比

Distributor

3.43B

85.05%

Direct

602.90M

14.95%

股東統計

更新時間: 2月21日週五

持股股東

股東類型

持股股東

股東統計

佔比

The Vanguard Group, Inc.

11.82%

BlackRock Institutional Trust Company, N.A.

6.17%

State Street Global Advisors (US)

4.26%

Baillie Gifford & Co.

3.73%

Capital Research Global Investors

3.67%

Other

70.36%

持股股東

股東統計

佔比

The Vanguard Group, Inc.

11.82%

BlackRock Institutional Trust Company, N.A.

6.17%

State Street Global Advisors (US)

4.26%

Baillie Gifford & Co.

3.73%

Capital Research Global Investors

3.67%

Other

70.36%

股東類型

股東統計

佔比

Investment Advisor

44.84%

Investment Advisor/Hedge Fund

35.69%

Hedge Fund

6.59%

Research Firm

3.56%

Pension Fund

2.27%

Bank and Trust

1.61%

Sovereign Wealth Fund

1.44%

Individual Investor

0.38%

Venture Capital

0.34%

Other

3.27%

機構持股

更新時間: 1月19日週日

報告期間

機構數

持股數

持股佔比

持股變動

2025Q1

2198

383.01M

97.68%

-27.58M

2024Q4

2220

380.88M

97.47%

-26.96M

2024Q3

2145

382.31M

97.83%

-30.58M

2024Q2

2115

397.02M

99.11%

-4.31M

2024Q1

2093

389.18M

98.33%

-19.87M

2023Q4

2081

398.01M

103.26%

+83.33K

2023Q3

1994

389.89M

100.89%

-11.88M

2023Q2

1952

389.17M

100.78%

-12.73M

2023Q1

1908

390.83M

100.84%

-11.09M

2022Q4

1889

389.49M

100.81%

-14.66M

股東持股明細

名稱

持股數

佔比

持股變動

變動比例

公告日期

The Vanguard Group, Inc.

46.36M

11.82%

-900.98K

-1.91%

Dec 31, 2024

BlackRock Institutional Trust Company, N.A.

24.18M

6.17%

+3.21K

+0.01%

Dec 31, 2024

State Street Global Advisors (US)

16.69M

4.26%

+19.76K

+0.12%

Dec 31, 2024

Baillie Gifford & Co.

14.61M

3.73%

-404.87K

-2.70%

Dec 31, 2024

Capital Research Global Investors

14.37M

3.67%

-3.58M

-19.93%

Dec 31, 2024

Sands Capital Management, LLC

11.11M

2.83%

+790.30K

+7.66%

Dec 31, 2024

Geode Capital Management, L.L.C.

9.99M

2.55%

+56.09K

+0.56%

Dec 31, 2024

Invesco Capital Management (QQQ Trust)

8.08M

2.06%

+108.41K

+1.36%

Feb 28, 2025

Nuveen LLC

7.82M

2%

+61.83K

+0.80%

Dec 31, 2024

Jennison Associates LLC

7.64M

1.95%

+710.86K

+10.25%

Dec 31, 2024

持股ETF

更新時間: 4月6日週日

機構名稱

佔比

First Trust Nasdaq Lux Digi Health Solutions ETF

9.74%

Simplify Market Neutral Equity Long/Short ETF

9%

Langar Global HealthTech ETF

6.72%

Global X Internet of Things ETF

4.93%

Touchstone Sands Capital US Select Growth ETF

4.63%

Harbor Health Care ETF

4.29%

Motley Fool Mid-Cap Growth ETF

3.88%

Fidelity Digital Health ETF

3.8%

Motley Fool Global Opportunities ETF

3.63%

Global X Telemedicine & Digital Health ETF

3.55%

First Trust Nasdaq Lux Digi Health Solutions ETF

佔比9.74%

Simplify Market Neutral Equity Long/Short ETF

佔比9%

Langar Global HealthTech ETF

佔比6.72%

Global X Internet of Things ETF

佔比4.93%

Touchstone Sands Capital US Select Growth ETF

佔比4.63%

Harbor Health Care ETF

佔比4.29%

Motley Fool Mid-Cap Growth ETF

佔比3.88%

Fidelity Digital Health ETF

佔比3.8%

Motley Fool Global Opportunities ETF

佔比3.63%

Global X Telemedicine & Digital Health ETF

佔比3.55%

分紅派息

近5年累計派現 0.00 美元

公告日期

分紅計劃

股權登記日

現金發放日

除權除息日

暫無數據

拆合股

公告日期

類型

比率

Mar 28, 2022

Split

1>4

公告日期

類型

比率

Mar 28, 2022

Split

1>4

Dexcom Inc

70.735USD

Dexcom Inc

70.735

概覽

公司